aldosterone synthase inhibitors (Elicio Therapeutics)

N/A

Report date: 2025/01/26 18:09:54
NME

Base Information

Drug Namealdosterone synthase inhibitors (Elicio Therapeutics)
Drug Alias Namealdosterone synthase inhibitors (ElexoPharm)aldosterone synthase inhibitors (Merck & Co)aldosterone synthase inhibitors (Angion Biomedica)CYP11B2 Inhibitors (Angion Biomedica)aldosterone synthase inhibitors (Merck & Co) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsHyperaldosteronismHypertensionCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElexoPharm Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics Inc
Inactive CompaniesElexoPharm GmbhMerck & Co Inc
Active IndicationsHyperaldosteronismHypertensionKidney Failure, Chronic
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A